Sorted By:

Relevance


Nearly 4.5 million jobs and counting

PhRMA  |  Blog Post

From the biopharmaceutical scientists working in labs to the employees on the front lines of manufacturing and distribution, each and every biopharmaceutical sector worker is instrumental in bringing new medicines to patients, strengthening the U.S. economy and maintaining our competitiveness in the global marketplace.
http://catalyst.phrma.org/nearly-4.5-million-jobs-and-counting

The Biopharmaceutical Research and Development Process

PhRMA  |  Graphic

...
https://www.phrma.org/graphic/the-biopharmaceutical-research-and-development-process

PhRMA Statement: Drug Quality and Security Act

PhRMA  |  Press Release

Since 2000, PhRMA member companies have invested approximately $550 billion in the search for new treatments and cures, including an estimated $48.5 billion in 2012 alone.
https://www.phrma.org/press-release/phrma-statement-drug-quality-and-security-act

Executive Assistant – Law Department

PhRMA  |  PhRMA Career

Take the lead in planning and coordinating departmental meetings and events, including with member companies and external stakeholders; oversee all meeting planning tasks and logistics, etc. 
https://www.phrma.org

Expanding Access to Opioid and Heroin Overdose Reversal Agents

PhRMA  |  Policy Paper

While 94% of prescription opioids are generic, the Pharmaceutical Research and Manufacturers of America (PhRMA) and its members are committed to working with others to collectively address this complex public health challenge.
https://www.phrma.org/policy-paper/expanding-access-to-opioid-and-heroin-overdose-reversal-agents

PhRMA to Bestow New Research and Hope Award

PhRMA  |  Press Release

Read more on The Catalyst: Research and Hope Award: Celebrating Research and Hope in Battle Against Alzheimer's The Pharmaceutical Research and Manufacturers of America (PhRMA) represents the country’s leading pharmaceutical research and biotechnology companies, which are devoted to inventing medicines that allow patients to live longer, healthier, and more productive lives.
https://www.phrma.org/press-release/phrma-to-bestow-new-research-and-hope-award

Thanking Research and Hope honorees for their efforts fighting cancer

PhRMA  |  Blog Post

On behalf of PhRMA and the co-sponsors of the 2015 Research and Hope Awards, we thank you for your contributions to this important effort.
http://catalyst.phrma.org/thanking-research-and-hope-honorees-for-their-efforts-fighting-cancer

The Challenge of Developing New Treatments and Cures

PhRMA  |  Video

Developing new treatments and cures is a challenging and costly undertaking.
https://www.phrma.org/video/the-challenge-of-developing-new-treatments-and-cures

Costs and Consequences of Not Treating Diseases

PhRMA  |  Blog Post

We look forward to sharing more about the benefits of medicines and hope that you will share your thoughts to the comments section below.
http://catalyst.phrma.org/costs-and-consequences-of-not-treating-diseases

Prescription Drug Misuse, Abuse & Disposal

PhRMA  |  From PhRMA

Examples include needles, syringes and lancets.
https://www.phrma.org/advocacy/safety/prescription-misuse-abuse

The Human and Economic Costs of Chronic Disease

Chartpack  |  From Our Network

...
http://chartpack.phrma.org/2016-perspective/chapter-6/the-human-and-economic-costs-of-chronic-disease

Sources of Outpatient Drug Coverage for Seniors and the Disabled

Chartpack  |  From Our Network

Medicare Part D plans covered about 35.7 million beneficiaries in 2013....
http://chartpack.phrma.org/programs-chartpack/medicines-in-medicare/sources-of-outpatient-drug-coverage-for-seniors-and-the-disabled

340B Then & Now

PhRMA  |  Graphic

A closer look at how the 340B program has evolved since its creation in 1992....
https://www.phrma.org/graphic/340b-then-and-now

The US Prescription Drug Lifecycle Promotes Innovation and Affordability

Chartpack  |  From Our Network

Since 2006, the daily cost for the top-10 therapy areas in Medicare Part D has fallen by nearly half....
http://chartpack.phrma.org/programs-chartpack/medicines-in-medicare/the-us-prescription-drug-lifecycle-promotes-innovation-and-affordability

Medicare Monday: Part B and biosimilars, part 2

PhRMA  |  Blog Post

While the impact of CMS’ policy change remains to be seen, there is a risk that CMS’ reimbursement changes could have the unintended consequence of stifling innovation and patient access in this emerging market.   
http://catalyst.phrma.org/medicare-monday-part-b-and-biosmilars-part-2

Diabetes: An Example of Underdiagnosis and Undertreatment

Chartpack  |  From Our Network

...
http://chartpack.phrma.org/2016-perspective/chapter-6/diabetes-an-example-of-underdiagnosis-and-undertreatment

Medicaid

PhRMA  |  From PhRMA

Federal law requires manufacturers to pay rebates on many medicines sold to Medicaid beneficiaries, and often states negotiate for additional discounts.
https://www.phrma.org/advocacy/access/medicaid

HIV/AIDS: Then and Now

From Hope To Cures  |  From Our Network

...
http://www.fromhopetocures.org/infographic/hiv/aids-then-and-now

Continuing progress and promise in pediatric drug development

PhRMA  |  Blog Post

Looking forward, several key trends hold promise for future pediatric research and development.
http://catalyst.phrma.org/continuing-progress-and-promise-in-pediatric-drug-development

Foster the Development and Use of ADFs

PhRMA  |  Policy Paper

The challenge of prescription drug abuse is multifaceted and requires a multi-pronged approach that ensures that patients with legitimate medical needs receive the treatments they need, offers a range of options for prescribers and patients to appropriately treat acute and chronic pain, and fosters the development of medications to treat addiction and address opioid overdose.
https://www.phrma.org/policy-paper/foster-the-development-and-use-of-adfs

Nearly 90 Medicines and Vaccines In Development for HIV/AIDS

PhRMA  |  Press Release

“The disease poses a complex problem, and we in the biopharmaceutical research industry know as well as anyone that it will require a complex solution, said PhRMA President and CEO, John J.
https://www.phrma.org/press-release/nearly-90-medicines-and-vaccines-in-development-for-hiv/aids

Empowering consumers and improving access to important clinical information

PhRMA  |  Blog Post

Check out our other videos in the Coverage Classroom, and learn about more solutions to engage and empower consumers at AccessBetterCoverage.org.
http://catalyst.phrma.org/empowering-consumers-and-improving-access-to-important-clinical-information

Video: How can biomarkers and surrogate endpoints enhance R&D of medicines?

PhRMA  |  Blog Post

Read more about proactive policy solutions to modernize the FDA and deliver innovative treatments to patients here.
http://catalyst.phrma.org/video-how-can-biomarkers-and-surrogate-endpoints-enhance-r-and-d-of-medicines

New Report: Clinical Trials and the Impact on State Economies

PhRMA  |  Blog Post

This analysis provides a new lens through which to view the economic and scientific footprint of the U.S. biopharmaceutical industry. 
http://catalyst.phrma.org/new-report-clinical-trials-and-the-impact-on-state-economies

What Access and Affordability Means for Chronic Disease Patients

PhRMA  |  Blog Post

Also visit the Access Better Coverage website for information that helps you better understand health insurance so you have the information you need to choose the plan that is best for you and your family.
http://catalyst.phrma.org/what-access-and-affordability-means-for-chronic-disease-patients

You have reviewed the first 175 results out of 2501. Each page contains 25 results. You're on page 7.

prev 7 8 9 10 11 12 next